According to Fortune Business Insights, the global cardiovascular ultrasound market was valued at USD 2.58 billion in 2025. The market is projected to grow from USD 2.74 billion in 2026 to USD 4.33 billion by 2034, registering a compound annual growth rate (CAGR) of 5.9% during 2026–2034. North America dominated the market with a 33.33% share in 2025.
Cardiovascular ultrasound, primarily echocardiography, is a non-invasive diagnostic imaging technology used to assess heart structure, chamber size, wall movement, valve function, and blood flow. It enables clinicians to evaluate cardiac conditions in real time and supports disease diagnosis, treatment planning, and ongoing patient monitoring.
Market growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for early diagnosis, technological advancements, and the expansion of diagnostic imaging services across hospitals and specialized healthcare facilities.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiovascular-ultrasound-market-116025
Key Market Trends
AI-Enabled Cardiovascular Imaging
Artificial intelligence is becoming an important trend in cardiovascular ultrasound. AI-powered systems can automate measurements, support image acquisition, improve consistency, and simplify reporting. These capabilities help clinicians streamline diagnostic workflows and make cardiac assessments more efficient.
For instance, Fortune Business Insights highlights Philips' integration of AI applications into its EPIQ CVx and Affiniti CVx systems, including automated wall-motion scoring and three-dimensional quantification of mitral regurgitation.
Growth of Handheld Ultrasound
Portable and handheld ultrasound devices are expanding access to cardiac imaging in emergency departments, outpatient facilities, and point-of-care settings. AI-guided scanning can help clinicians acquire diagnostic-quality images more efficiently, including in facilities with limited access to experienced imaging specialists.
Market Growth Drivers
Rising Cardiovascular Disease Burden
The growing incidence of cardiovascular conditions is increasing the need for screening, diagnosis, follow-up examinations, and procedural guidance. Cardiovascular ultrasound is widely used because it is non-invasive, repeatable, and suitable for inpatient, outpatient, emergency, and perioperative settings.
Increasing Demand for Early Diagnosis
Early identification of structural abnormalities, impaired cardiac function, and valvular disorders supports timely clinical intervention. Healthcare providers are increasingly relying on echocardiography to monitor disease progression and assess treatment outcomes, supporting continued demand for ultrasound systems.
Expansion of Healthcare Infrastructure
Investment in hospitals, ambulatory surgical centers (ASCs), specialty clinics, and diagnostic imaging centers is generating demand for advanced cardiac imaging equipment. Growing access to healthcare in emerging economies also creates opportunities for manufacturers to expand distribution and introduce cost-effective solutions.
Market Segmentation
Fortune Business Insights segments the cardiovascular ultrasound market by product, application, end user, and region.
By Product: The market includes systems and accessories and consumables. Systems held the leading position in 2025, supported by the adoption of advanced imaging technologies and the expansion of healthcare facilities. Accessories and consumables are projected to grow at a CAGR of 7.5% during the forecast period.
By Application: Categories include cardiac structure and function assessment, valvular heart disease assessment, heart failure and cardiomyopathy evaluation, coronary and vascular imaging guidance, congenital heart disease assessment, and others. Cardiac structure and function assessment is expected to account for 32.7% of the market in 2026. Valvular heart disease assessment is projected to grow at a CAGR of 6.1%.
By End User: The market includes hospitals and ASCs, specialty clinics, diagnostic imaging centers, and other users. Hospitals and ASCs are projected to hold a 65.3% share in 2026, reflecting their high volume of cardiac cases, inpatient imaging needs, and complex procedures. Specialty clinics are expected to grow at a CAGR of 7.1%.
Regional Analysis
North America
North America led the market with a value of USD 0.86 billion in 2025. Strong healthcare infrastructure, adoption of advanced diagnostic technologies, and established cardiac care services support regional demand. The U.S. market is projected to reach USD 0.80 billion in 2026.
Europe
Europe's cardiovascular ultrasound market is projected to reach USD 0.72 billion in 2026, growing at a CAGR of 5.3% during the forecast period. Its established diagnostic imaging network and expanding availability of advanced ultrasound technologies contribute to market development. Germany is projected to reach USD 0.15 billion in 2026, while the U.K. is expected to reach USD 0.12 billion.
Asia Pacific
Asia Pacific is projected to reach USD 0.80 billion in 2026, supported by improving healthcare infrastructure, a rising cardiovascular disease burden, and increasing investment in diagnostic imaging. China's market is expected to reach USD 0.28 billion, Japan's USD 0.15 billion, and India's USD 0.11 billion in 2026.
Latin America and the Middle East and Africa are also expected to experience growth as access to cardiac diagnostics improves. Latin America's market is projected to reach approximately USD 0.19 billion in 2026.
Market Challenges
The high cost of advanced cardiovascular ultrasound systems remains a significant challenge, particularly for smaller healthcare facilities and emerging markets. Systems equipped with AI, three-dimensional and four-dimensional imaging, and procedural guidance features require substantial investment.
Additional challenges include ongoing maintenance, software upgrades, training expenses, and dependence on skilled operators. Shortages of trained professionals can limit equipment utilization, delay examinations, and affect access to specialized cardiac imaging services.
Competitive Landscape
The market features established medical technology companies competing through product innovation, AI integration, global distribution, and improvements in imaging performance.
Key companies highlighted by Fortune Business Insights include GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers AG. Their broad product portfolios and international distribution networks strengthen their competitive positions. Other market participants seek to differentiate their offerings through portable systems, automated measurements, and workflow-enhancing technologies.
Market Outlook
The global cardiovascular ultrasound market is expected to expand steadily through 2034, reaching a projected USD 4.33 billion. Increasing cardiovascular disease prevalence, demand for early diagnosis, and advancements in AI-enabled and handheld ultrasound technologies are expected to support future growth.
Although high equipment costs and operator-skill requirements remain challenges, investments in healthcare infrastructure and broader access to cardiac diagnostics create opportunities. Manufacturers offering reliable, efficient, and cost-effective imaging solutions are positioned to benefit from the market's continued development.
Comments